|
Volumn 24, Issue 5-6, 2006, Pages 540-541
|
Is bcl-2 a key molecule in the abnormal immune response of hemodialysis patients?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ERYTHROPOIETIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PROTEIN BCL 2;
APOPTOSIS;
AUTOIMMUNE DISEASE;
CELL DEATH;
CELL SURVIVAL;
CHRONIC KIDNEY DISEASE;
EDITORIAL;
HEMODIALYSIS;
HUMAN;
IMMUNE RESPONSE;
LYMPHOCYTE;
METABOLIC ACIDOSIS;
PERIPHERAL BLOOD MONONUCLEAR CELL;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
UREMIA;
APOPTOSIS;
HUMANS;
IMMUNE SYSTEM DISEASES;
KIDNEY DISEASES;
LEUKOCYTES, MONONUCLEAR;
PROTO-ONCOGENE PROTEINS C-BCL-2;
RENAL DIALYSIS;
|
EID: 33845929860
PISSN: 02535068
EISSN: None
Source Type: Journal
DOI: 10.1159/000097076 Document Type: Editorial |
Times cited : (1)
|
References (5)
|